Advertisement
Screener

Lear Corp (LEA) Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount

2.8 / 5 stars · 68/120 Roast Me

Lear Corp Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount

Lear Corp (LEA) reported Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount of $2.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount · last filed 2026-02-13

  • Lear Corp equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2023-12-31 was $2.00M.
  • Lear Corp equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2023-09-30 was $0.00.
  • Lear Corp equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2023-07-01 was $0.00.
  • Lear Corp equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2023-04-01 was $5.00M.
  • Lear Corp equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2025 was $2.60M.
  • Lear Corp equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2023 was $7.00M.
  • Lear Corp equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2021 was $1.00M, a 75.00% decline from fiscal 2020.
  • Lear Corp equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2020 was $4.00M, a 20.00% decline from fiscal 2019.
Period endEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 3 monthEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 6 monthEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 6 month as first filedEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 9 monthEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month
2025-12-31$2.60M
10-K · filed 2026-02-13
2023-12-31$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
$2.00M
derived: sum of 2 quarters · filed 2026-02-13
$2.00M
derived: sum of 3 quarters · filed 2026-02-13
$7.00M
10-K · filed 2026-02-13
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24
$0.00
derived: sum of 2 quarters · filed 2024-10-24
$5.00M
10-Q · filed 2024-10-24
2023-07-01$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25
$5.00M
10-Q · filed 2024-07-25
-$5.00M
10-Q · filed 2023-08-01
2023-04-01$5.00M
10-Q · filed 2024-04-30
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08
$0.00
derived: sum of 2 quarters · filed 2024-02-08
$1.00M
derived: sum of 3 quarters · filed 2024-02-08
$1.00M
10-K · filed 2024-02-08
2021-10-02$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01
$1.00M
derived: sum of 2 quarters · filed 2022-11-01
$1.00M
10-Q · filed 2022-11-01
2021-07-03$1.00M
10-Q · filed 2022-08-02
$1.00M
10-Q · filed 2022-08-02
2020-12-31$4.00M
10-K · filed 2021-02-10
$4.00M
10-K · filed 2023-02-09
2019-12-31$5.00M
10-K · filed 2021-02-10
$5.00M
10-K · filed 2022-02-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Garrett Motion Inc. (GTX)$4.732B9.95
GENTEX CORP (GNTX)United States$4.643B13.22
Atmus Filtration Technologies Inc. (ATMU)United States$3.656B19.39
Dorman Products, Inc. (DORM)United States$3.641B18.26
AUTOLIV INC (ALV)$8.345B13.55
Versigent PLC (VGNT)$3.205B
DANA Inc (DAN)United States$2.944B2.63
Aptiv PLC (APTV)$9.048B58.16
VISTEON CORP (VC)United States$2.398B16.55
Allison Transmission Holdings Inc (ALSN)United States$9.313B17.68